Congratulations first on a great set of results. And I wanted to know your views on the MFN policy, which means that the prices of drugs wanting to come down in the U.S. and what kind of effect will that have on the outsourcing by the global pharma companies?
So there will not be a positive or negative impact at all to the company itself. I'm not talking about us specifically. What will the outsourcing impact be in general?